A new type of MRI scan may distinguish active from chronic MS lesions without the need for injected contrast dye.

Anti-CD20 therapies and S1P receptor modulators seem to be equally effective for most people with late-onset MS, a real-world ...

The FDA agreed that the design of a Phase 3 trial testing privosegtor in optic neuritis could support a future approval ...

Decode Health and Circular Genomics will use AI to identify patterns in circular RNA in blood that may help diagnose and ...

This year's Bike MS event in Texas, the largest such U.S. fundraiser, brought in $9.2 million for research, advocacy, and ...

Researchers found the nerve damage biomarker NfL in menstrual fluid, meaning tampon-collected samples could help monitor ...

Columnist Ben Hofmeister shares his insights about living with MS, and says people with the disease don't have to figure it out on their own.

The first participant has been dosed in an investigator-led Phase 2 trial testing pegsebrenatide as a potential treatment for ...

The amount of sugar in the brain plays a key role in governing the activity of the brain cells that make myelin, a study ...

MS patients in the U.S. with commercial insurance wait more than 50 days on average for a first visit to a neurologist, a ...

The MSAA will host its 12th Improving Lives Benefit May 7, bringing together the MS community to raise funds and recognize ...

Eating greater amounts of ultra-processed foods is significantly associated with a higher likelihood MS in childhood or ...